Company / EPS (Basic)
Moderna EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$12.33
FY2025
5-year range
-$12.33 / $30.31
FY2021-FY2025
Trend
-158.0%
vs FY2024
Sector context
#205 of 208
Health Care
What the data says
Among 208 Health Care companies, Moderna is in the bottom 1% for eps (basic). Declined from $30.31 to $-12.33 over the past 2 years.
Based on SEC 10-K filings.
-12.33 in FY2025.
Declined from $30.31 to $-12.33 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 208This company -$12.33 Sector average -$0.88
▼
-1302.4% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 158.0% year-over-year.
- Ranks #205 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$12.33 | -158.0% |
| FY2024 | $21.26 | -29.9% |
| FY2023 | $30.31 | +1646.4% |
| FY2022 | -$1.96 | -26.5% |
| FY2021 | -$1.55 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026